Similar Papers

Paper Title
Journal
Date
Author
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability
Laura Passerini ... Rosa Bacchetta
The Journal of Allergy and Clinical Immunology | VOL. 128
Laura Passerini, et. al.Laura Passerini ... Rosa Bacchetta
13 Oct 2011
FOXP3 is a promising and potential candidate gene in generalised vitiligo susceptibility.
Parveen Jahan ... Surekha Tippisetty
Frontiers in Genetics | VOL. 6
Parveen Jahan, et. al.Parveen Jahan ... Surekha Tippisetty
22 Jul 2015
Correlation between FOXP3 expression and gastric cancer.
Guoxiao Guo ... Zhaohui Shi
Oncology Letters | VOL. 12
Guoxiao Guo, et. al.Guoxiao Guo ... Zhaohui Shi
17 Jun 2016
Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma
...
Zhonghua yi xue za zhi | VOL. 97
, et. al. ...
16 May 2017
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Janis M Taube ... Carlo B Bifulco
Journal for ImmunoTherapy of Cancer | VOL. 13
Janis M Taube, et. al.Janis M Taube ... Carlo B Bifulco
08 Jan 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Daniela Esposito ... Luigi Formisano
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniela Esposito, et. al.Daniela Esposito ... Luigi Formisano
01 Jan 2025
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Yi Sun ... Yuwen Zhu
Journal for ImmunoTherapy of Cancer | VOL. 13
Yi Sun, et. al.Yi Sun ... Yuwen Zhu
01 Jan 2025
Weal and woe of interleukin-18 in the T cell therapy of cancer
Christoph Kessel ... Hinrich Abken
Journal for ImmunoTherapy of Cancer | VOL. 13
Christoph Kessel, et. al.Christoph Kessel ... Hinrich Abken
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.